We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

50 hedge funds and large institutions have $11.9M invested in Actinium Pharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 14 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

367% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 3

325% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 4

112% more call options, than puts

Call options by funds: $3.47M | Put options by funds: $1.64M

32% more funds holding

Funds holding: 38 → 50 (+12)

27% more capital invested

Capital invested by funds: $9.37M → $11.9M (+$2.54M)

2.13% more ownership

Funds ownership: 8.28% → 10.4% (+2.1%)

Holders
50
Holders Change
+12
Holders Change %
+31.58%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
14
Reduced
3
Closed
4
Calls
$3.47M
Puts
$1.64M
Net Calls
+$1.83M
Net Calls Change
-$1.87M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.19M
2
Renaissance Technologies
Renaissance Technologies
New York
+$328K
3
Two Sigma Investments
Two Sigma Investments
New York
+$325K
4
Millennium Management
Millennium Management
New York
+$188K
5
Group One Trading
Group One Trading
Illinois
+$181K

Top Sellers

Rank Fund Capital Flow
1
Simplex Trading
Simplex Trading
Illinois
-$110K
2
ACM
ACT Capital Management
Pennsylvania
-$33K
3
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$32.4K
4
William Blair & Company
William Blair & Company
Illinois
-$14.8K
5
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$5.68K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
26
Rockefeller Capital Management
New York
$61K +$5.68K +1,000 +8%
TSS
27
Two Sigma Securities
New York
$61K +$71.7K +12,624 New
PCM
28
Perritt Capital Management
Illinois
$58K +$68.1K +12,000 New
LSA
29
Leonteq Securities AG
Switzerland
$39.5K +$45.4K +8,000 New
TRCT
30
Tower Research Capital (TRC)
New York
$28K +$27.1K +4,771 +461%
Wells Fargo
31
Wells Fargo
California
$25K +$131 +23 +0.5%
RG
32
Retirement Group
California
$15K – – –
Osaic Holdings
33
Osaic Holdings
Arizona
$14K – – –
CG
34
Cutler Group
California
$13K +$10.2K +1,800 +180%
Carson Wealth (CWM LLC)
35
Carson Wealth (CWM LLC)
Nebraska
$8K – – –
EL
36
EMFO LLC
Florida
$8K – – –
FDCDDQ
37
Federation des caisses Desjardins du Quebec
Quebec, Canada
$6.25K – – –
National Bank of Canada
38
National Bank of Canada
Quebec, Canada
$4K – – –
HFM
39
Hartford Financial Management
Connecticut
$3K – – –
GFPC
40
Global Financial Private Client
Florida
$1.32K – – –
CAPTRUST Financial Advisors
41
CAPTRUST Financial Advisors
North Carolina
$1K -$5.68K -1,000 -86%
BCV
42
Banque Cantonale Vaudoise
Switzerland
$1K – – –
Northwestern Mutual Wealth Management
43
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
Simplex Trading
44
Simplex Trading
Illinois
– -$110K -19,413 Closed
ACM
45
ACT Capital Management
Pennsylvania
– -$33K -6,500 Closed
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
– -$2K -406 Closed
CS
47
Credit Suisse
Switzerland
– +$6 +1 New
UBS Group
48
UBS Group
Switzerland
– +$204 +36 New
TCOV
49
Trust Company of Vermont
Vermont
– +$284 +50 New
TC
50
Truvestments Capital
Florida
– +$341 +60 New
1
2
3

ATNM Hedge Fund Activity: Q2 2022 in Review

50 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q2 2022, worth a combined $11.9M — up 27% from $9.37M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new ATNM positions and 4 closed out — a net gain of 13 holders — while 14 added to existing stakes and 3 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.19M. The largest seller was Simplex Trading, exiting entirely with an estimated $110K sold.

  • 50 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q2 2022, up from 38 in Q1 2022.
  • Funds reported $11.9M of Actinium Pharmaceuticals stock for Q2 2022, up 27% quarter-over-quarter.
  • 17 funds opened new Actinium Pharmaceuticals positions in Q2 2022 and 4 closed out, a net change of +13 holders.
  • The largest Actinium Pharmaceuticals buyer in Q2 2022 was Vanguard Group, an estimated $1.19M added.
  • The largest Actinium Pharmaceuticals seller in Q2 2022 was Simplex Trading, an estimated $110K sold.

Based on aggregated 13F filings for Q2 2022.